Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Inflammation

Inflammation

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Plasma metabolites, blood-borne microvesicles, and history of preeclampsia as predictors of coronary artery calcification in postmenopausal women.

American journal of physiology. Heart and circulatory physiology·2026

Same author

Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same author

Association between central adiposity and cognitive domain function in recently postmenopausal women: an analysis from the KEEPS-Cog substudy of the Kronos Early Estrogen Preventive Study.

Menopause (New York, N.Y.)·2025

Same author

The Genetic Associations Between Kidney Stones, Obesity, Type 2 Diabetes, and Hypertension.

Mayo Clinic proceedings·2025

Same author

Long-term effects of 4 years of menopausal hormone therapy on white matter integrity.

Menopause (New York, N.Y.)·2025

Same author

Longitudinal Study of the Vascular Glycocalyx and Urinary Podocyte Markers During Pregnancy.

Journal of the American Heart Association·2025

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Estrogen, inflammation, and platelet phenotype.

Virginia M Miller¹, Muthuvel Jayachandran, Kazumori Hashimoto

¹Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. miller.virginia@mayo.edu

Gender Medicine

|May 28, 2008

Summary

This summary is machine-generated.

Estrogen affects blood platelets, influencing their aggregation and secretion. Understanding these effects, particularly estrogen receptor beta

More Related Videos

On-Chip Endothelial Inflammatory Phenotyping

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

Related Experiment Videos

Last Updated: Jul 6, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

On-Chip Endothelial Inflammatory Phenotyping

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

Area of Science:

Endocrinology and Hematology
Molecular Biology and Pharmacology

Background:

Exogenous estrogenic therapies are linked to increased thrombosis risk.
The precise impact of estrogen on blood components, especially platelets, remains unclear.
Platelets play a crucial role in hemostasis and thrombosis.

Purpose of the Study:

To investigate the genomic and nongenomic effects of estrogen on platelet phenotype.
To elucidate how estrogen influences platelet function and contributes to thrombotic risk.

Main Methods:

Platelets were obtained from experimental animals with varying hormonal statuses.
Platelets were collected from women participating in the Kronos Early Estrogen Prevention Study.
Assays included platelet aggregation, secretion, protein expression, and thrombin generation.

Main Results:

Estrogen receptor beta (ERB) is the predominant estrogen receptor in circulating platelets.
Estrogenic treatment in ovariectomized animals reduced platelet aggregation and adenosine triphosphate (ATP) secretion.
Acute 17beta-estradiol exposure did not reverse lipopolysaccharide-induced decreases in platelet ATP secretion.
Thrombin generation correlated positively with circulating microvesicles expressing phosphatidylserine.

Conclusions:

Estrogen receptor beta plays a significant role in mediating estrogen's effects on platelets.
Estrogen can modulate platelet function, potentially influencing thrombotic events.
Evaluating estrogen's impact on platelets may offer novel strategies for identifying women at risk for thrombosis during estrogen therapy.